Magical
+66%
est. 2Y upside i
Rank
#751
Sector
Healthcare AI Automation
Est. Liquidity
~3Y
Data Quality
Data: MediumExpected 2-year common-stock upside is ~66% after assumed 20% dilution, driven by a 93% base case.
Last updated: August 3, 2026
Bull: Category leadership in healthcare AI agents opens an IPO/acquisition window, allowing a 6.0x forward multiple on $16.6M projected ARR, a $99M exit. After 20% assumed dilution, common upside is ~+200%.
Base: Exit multiple reverts to the lower end of public comparables (4.0x), producing a $66M exit. After 20% dilution, common upside is ~+93%.
Bear: Multiple compresses to 1.5x forward revenue, a $25M exit below the $41M liquidation preference; common stock is worth zero and returns -100%.
Preference Stack Risk
severeFunding Intensity
13180%$41M total funding vs $31.1M current valuation; preferred stack is $9.9M ahead of common at the current mark.
Dilution Risk
highNo financing since Jun 2022; with ~$41M raised and $10.4M revenue, a new round within 24 months is likely, implying 15-25% dilution.
Secondary Liquidity
noneNo secondary market activity; the only mark is a 2025 M&A offer, not employee tradability.
Engineering — 5 roles
- Junior Software Engineer, AI (New Grad OK) · San Francisco
- Senior Software Engineer, Agent Platform · San Francisco
- Senior Software Engineer, Agent Platform · Toronto
- +2 more →
Product Management — 3 roles
- AI Agent Deployment Engineering Manager · Toronto
- AI Forward Deployed Engineer · San Francisco
- Deployment Strategist · Toronto
Sales — 2 roles
- Healthcare Account Executive, Full Cycle · San Francisco
- Sales Development Representative (SDR) · Toronto Office Remote
Marketing — 1 role
- Brand Designer (Contractor PT) · Toronto
Operations — 1 role
- Talent Acquisition Lead · Remote
Product Design — 1 role
- Senior Product Designer · Toronto
Last updated: February 22, 2026
Questions to Ask at the Interview
Strategic questions based on Magical's data — designed to show you've done your homework.
- 1
“What is the current common-stock 409A price relative to the $31.1M M&A offer valuation, and what is the precise liquidation preference stack?”
- 2
“How does Magical plan to defend against UiPath and large AI labs entering healthcare workflow automation?”
- 3
“What percentage of the $10.4M ARR comes from the legacy text-expansion product versus the new agentic AI workflows, and what is net revenue retention?”
Community
Valuation Sentiment
Our model estimates +66% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.